Matej Markota, M.D.

Publicaciones

  1. Markota M, Coombes BJ, Bieber ED, Kirchoff RW, Bobo WV, Croarkin PE. Relative Age Effect on Problematic Alcohol Use in Adolescents. J Child Adolesc Psychopharmacol. 2021 Jul 27 Epub 2021 July 27
    View PubMed
  2. Kirchoff RW, Mohammed NM, McHugh J, Markota M, Kingsley T, Leung J, Burton MC, Chaudhary R. Naltrexone Initiation in the Inpatient Setting for Alcohol Use Disorder: A Systematic Review of Clinical Outcomes. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr; 5 (2):495-501 Epub 2021 Apr 08
    View PubMed
  3. Coombes BJ, Markota M, Mann JJ, Colby C, Stahl E, Talati A, Pathak J, Weissman MM, McElroy SL, Frye MA, Biernacka JM. Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores. Transl Psychiatry. 2020 Sep 18; 10 (1):314 Epub 2020 Sept 18
    View PubMed
  4. Ho AMC, Cabello-Arreola A, Markota M, Heppelmann CJ, Charlesworth MC, Ozerdem A, Mahajan G, Rajkowska G, Stockmeier CA, Frye MA, Choi DS, Veldic M. Label-free proteomics differences in the dorsolateral prefrontal cortex between bipolar disorder patients with and without psychosis. J Affect Disord. 2020 Jun 1; 270:165-173 Epub 2020 Apr 08
    View PubMed
  5. Markota M, McKean AJ, Romanowicz M, Schak KM, Croarkin PE, Vande Voort JL. Rehospitalization to a child and adolescent psychiatry unit: Role of trauma and bullying. Gen Hosp Psychiatry. 2018 Nov - Dec; 55:10-14 Epub 2018 Aug 30
    View PubMed
  6. Markota M, Coombes BJ, Larrabee BR, McElroy SL, Bond DJ, Veldic M, Colby CL, Chauhan M, Cuellar-Barboza AB, Fuentes M, Kung S, Prieto ML, Rummans TA, Bobo WV, Frye MA, Biernacka JM. Association of schizophrenia polygenic risk score with manic and depressive psychosis in bipolar disorder. Transl Psychiatry. 2018 Sep 10; 8 (1):188 Epub 2018 Sept 10
    View PubMed
  7. Pantazopoulos H, Wiseman JT, Markota M, Ehrenfeld L, Berretta S. Decreased Numbers of Somatostatin-Expressing Neurons in the Amygdala of Subjects With Bipolar Disorder or Schizophrenia: Relationship to Circadian Rhythms. Biol Psychiatry. 2017 Mar 15; 81 (6):536-547 Epub 2016 Apr 16
    View PubMed
  8. Markota M, Morgan RJ. Treatment of Generalized Anxiety Disorder with Gabapentin. Case Rep Psychiatry. 2017; 2017:6045017 Epub 2017 Dec 14
    View PubMed
  9. Markota M, Rummans TA, Bostwick JM, Lapid MI. Benzodiazepine Use in Older Adults: Dangers, Management, and Alternative Therapies. Mayo Clin Proc. 2016 Nov; 91 (11):1632-1639
    View PubMed
  10. Berretta S, Pantazopoulos H, Markota M, Brown C, Batzianouli ET. Losing the Sugar Coating: Potential Impact of Perineuronal Net Abnormalities on Interneurons in Schizophrenia Schizophr Res.. 2015 Sep; 167(1-3):18-27.
  11. Pantazopoulos H, Markota M, Jaquet F, Ghosh D, Wallin A, Santos A, Caterson B, Berretta S. Aggrecan and Chondroitin-6-sulfate Abnormalities in Schizophrenia and Bipolar Disorder: a Postmortem Study on the Amygdala Transl Psychiatry. 2015 Jan 20; 5:e496.
  12. Markota M, Mehta U, Solis M. Highlights from the Biennial International Congress on Schizophrenia Research (ICOSR), March 28-April 1, 2015. Clinical Schizophrenia and Related Psychoses. 2015; 9(2):60-4.
    View PubMed
  13. Markota M, Sin J, Pantazopoulos H, Jonilionis R, Berretta S. Reduced Dopamine Transporter Expression in the Amygdala of Subjects Diagnosed with Schizophrenia Schizophr Bull.. 2014; 40:984-91.
  14. Markota M, Vranic A, Bresjanac M. Contemporary psychosurgery: Deep brain stimulation for the treatment of refractory depression Zdravstveni Vestnik. 2010; 79:433-441.
PST-20466625